Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Vandana Singh

Why Cutera's Shares Are Soaring Today

  • The FDA has granted 510(k) clearance to Cutera Inc's (NASDAQ:CUTR) AviClear for acne.
  • The Company notes that AviClear is the first and only energy-based device to receive this designation to treat mild, moderate, and severe acne.
  • AviClear is a laser treatment that offers a safe, prescription-free solution for acne.
  • In addition to reducing existing acne, clinical trials show that future breakout episodes are shorter, less intense, and infrequent following the AviClear procedure. 
  • Further, acne clearance results continue to improve over time, demonstrating the long-term efficacy of the treatment. 
  • Significantly, no pain mitigation was utilized or required by any clinical study participant.
  • Price Action: CUTR shares are up 7.41% at $49.00 during the premarket session on the last check Friday
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.